PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33196992-4	2021	Adjusted concentrations of Apo B were positively associated with perfluorooctanoic acid (PFOA beta = 0.03878, p < 0.01), perfluorooctane sulfonic acid (PFOS beta = .02029, p = 0.02), and perfluorononanoic acid (PFNA beta = .01968, p = .03) for nondiabetics who were not taking lipid lowering medications.	perfluorooctane sulfonic acid	121-150	apolipoprotein B	Homo sapiens	27-32	
33196992-4	2021	Adjusted concentrations of Apo B were positively associated with perfluorooctanoic acid (PFOA beta = 0.03878, p < 0.01), perfluorooctane sulfonic acid (PFOS beta = .02029, p = 0.02), and perfluorononanoic acid (PFNA beta = .01968, p = .03) for nondiabetics who were not taking lipid lowering medications.	perfluorooctane sulfonic acid	152-156	apolipoprotein B	Homo sapiens	27-32	
31376682-9	2019	Furthermore, AKR7A bioactivity was inactivated after treatment with perfluorooctane sulfonate (PFOS), an ApoB activator, in AFB1-dosed HepG2 cells.	perfluorooctane sulfonic acid	68-93	apolipoprotein B	Homo sapiens	105-109	
31376682-9	2019	Furthermore, AKR7A bioactivity was inactivated after treatment with perfluorooctane sulfonate (PFOS), an ApoB activator, in AFB1-dosed HepG2 cells.	perfluorooctane sulfonic acid	95-99	apolipoprotein B	Homo sapiens	105-109